Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $4.894B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 5,774,016 | $663M | 13.5% | $48.76 | +46.2% | COMMON STOCK | 03940C100 |
| RVMD | REVOLUTION MEDICINES INC | 6,655,703 | $647M | 13.2% | $38.36 | +168.6% | COM | 76155X100 |
| NUVL | NUVALENT INC | 5,324,433 | $545M | 11.1% | $61.16 | +69.5% | COM | 670703107 |
| PCVX | VAXCYTE INC | 4,793,020 | $279M | 5.7% | $55.04 | -4.1% | COM | 92243G108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 7,365,038 | $232M | 4.7% | $21.00 | +34.2% | COM | 28036F105 |
| GMAB | GENMAB A/S | 7,967,836 | $214M | 4.4% | $30.28 | — | SPONSORED ADS | 372303206 |
| INSM | INSMED INC | 1,254,488 | $205M | 4.2% | $159.03 | 0.0% | COM PAR $.01 | 457669307 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,562,154 | $180M | 3.7% | $28.61 | +143.6% | COM | 87650L103 |
| BLTE | BELITE BIO INC | 1,114,784 | $178M | 3.6% | $159.44 | — | SPONSORED ADS | 07782B104 |
| ERAS | ERASCA INC | 10,392,702 | $168M | 3.4% | $2.22 | +352.2% | COM | 29479A108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3,574,048 | $142M | 2.9% | $39.72 | — | SPONSORED ADS | 152309100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 8,020,576 | $120M | 2.4% | $10.16 | +150.4% | COM | 68062P106 |
| TERN | TERNS PHARMACEUTICALS INC | 2,216,499 | $117M | 2.4% | $32.21 | +16.3% | COM | 880881107 |
| ORKA | ORUKA THERAPEUTICS INC | 2,320,316 | $114M | 2.3% | $29.07 | +11.6% | COM | 687604108 |
| APGE | APOGEE THERAPEUTICS INC | 1,348,243 | $113M | 2.3% | $49.13 | +47.0% | COM | 03770N101 |
| SYRE | SPYRE THERAPEUTICS INC | 1,957,266 | $98.72M | 2.0% | $28.17 | +22.6% | COM NEW | 00773J202 |
| CYTK | CYTOKINETICS INC | 1,480,857 | $97.6M | 2.0% | $64.44 | 0.0% | COM NEW | 23282W605 |
| ABVX | ABIVAX SA | 772,473 | $86.01M | 1.8% | $84.90 | — | SPONSORED ADS | 00370M103 |
| TNGX | TANGO THERAPEUTICS INC | 4,009,679 | $83.88M | 1.7% | $11.91 | 0.0% | COM | 87583X109 |
| MAZE | MAZE THERAPEUTICS INC | 2,744,399 | $81.92M | 1.7% | $44.04 | 0.0% | COM | 578784100 |
| TYRA | TYRA BIOSCIENCES INC | 2,054,991 | $78.71M | 1.6% | $30.25 | 0.0% | COM | 90240B106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,148,893 | $61.59M | 1.3% | $24.89 | +23.9% | COM | 92790C104 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,226,080 | $60.27M | 1.2% | $33.97 | +33.9% | COM | 80706P103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 625,000 | $57.74M | 1.2% | $96.57 | 0.0% | COM | 604749101 |
| EYPT | EYEPOINT INC | 3,142,437 | $40.51M | 0.8% | $12.73 | +19.6% | COM NEW | 30233G209 |
| LXEO | LEXEO THERAPEUTICS INC | 6,184,134 | $35.5M | 0.7% | $8.76 | -14.0% | COM | 52886X107 |
| MANE | VERADERMICS INC | 525,000 | $33.15M | 0.7% | $63.15 | — | COMMON STOCK | 922967104 |
| VOR | VOR BIOPHARMA INC | 1,750,000 | $31.22M | 0.6% | $18.62 | -24.9% | COM NEW | 929033207 |
| URGN | UROGEN PHARMA LTD | 1,703,949 | $30.64M | 0.6% | $18.17 | +14.7% | COM | M96088105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 545,287 | $26.28M | 0.5% | $48.20 | — | SPONSORED ADS | 86366E106 |
| IVA | INVENTIVA SA | 4,000,000 | $22.2M | 0.5% | $4.65 | — | ADS | 46124U107 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,701,217 | $21.55M | 0.4% | $11.51 | -6.5% | COM | 68622P109 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 665,251 | $18.46M | 0.4% | $32.21 | -11.5% | COM NEW | 045396207 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 868,213 | $7.771M | 0.2% | $11.74 | — | COM NEW | 107924102 |
| KLRS | KALARIS THERAPEUTICS INC | 700,000 | $4.039M | 0.1% | $6.39 | +46.6% | COM | 482929106 |